Last10K.com

Ironwood Pharmaceuticals Inc (IRWD) SEC Filing 8-K Material Event for the period ending Friday, March 8, 2019

Ironwood Pharmaceuticals Inc

HISTORY TOOLS
CIK: 1446847 Ticker: IRWD

View differences made from one to another to evaluate Ironwood Pharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ironwood Pharmaceuticals Inc.

Continue

Assess how Ironwood Pharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ironwood Pharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: IRWD
CIK: 1446847
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-013536
Submitted to the SEC: Fri Mar 08 2019 9:00:47 AM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Friday, March 8, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/irwd/0001104659-19-013536.htm